 |
|
Glycoprotein hormone receptors
January 17, 2006A perfect model to study GPCR activation and dimerization
We have aspired at understanding and further dissecting the molecular mechanism of activation of the Glycoprotein hormone receptors (GpHr), members of the G protein coupled receptor (GPCR) superfamily.
First, we have focused on a network of polar interactions among highly conserved residues within the transmembrane (TM) region. Combination of site-directed mutagenesis and molecular dynamics simulations applied to the thyrotropin receptor (TSHr) have allowed identification of the residue N7.49, belonging to the canonical NPxxY motif of TM 7, as a molecular control in the mechanism of TSHr activation. N7.49 appears to adopt two different conformations in the inactive and active states. The inactive conformation is maintained by interactions with residues T6.43 and D6.44 (GpHr specific residues, located at the bottom of TM 6). Mutations that disrupt these interactions result in constitutive receptor activation. Our data suggest that upon receptor activation N7.49 undergoes a conformational change and that it might interact with D2.50 and a charged residue not identified yet. Moreover, the conserved L2.46 of the (N/S)LxxxD motif also seems to play a significant role in restraining the receptor in the inactive state.
On the other hand, growing body of evidence indicates that the GPCRs function as oligo(di)mers. Therefore we have used the GpHr family as a model to study the possible functional consequences of this oligomerization process. We first demonstrated in recombinant living cells, with a combination of biophysical methodologies (BRET and HTRF/FRET), that the TSH and lutropin (LH/CG) receptors form homo- and heterodimers, via interactions involving, primarily, their heptahelical domains. The large hormone-binding ectodomains were not essential for dimerization but adjusted protomer interaction. Contrary to a previous report, activation did not affect dimerization. Functional complementation, chieved by coexpression of mutant receptors unable to bind or signal, indicates that TSHr dimers may function as a single functional unit. Notably, heterologous binding-competition studies performed with heterodimers between TSHr and LH/CG-TSHr chimeras, demonstrated the unsuspected existence of strong negative cooperativity of hormone binding. Furthermore, radioligand desorption experiments highlighted an allosteric behavior in TSHr (confirmed in a native system) and, to a lesser extent, in LH/CGr and FSHr homodimers. This phenomenon seems to be a common property within the entire GPCR superfamily.
Elhuyar Fundazioa
On the other hand, growing body of evidence indicates that the GPCRs function as oligo(di)mers. Therefore we have used the GpHr family as a model to study the possible functional consequences of this oligomerization process. We first demonstrated in recombinant living cells, with a combination of biophysical methodologies (BRET and HTRF/FRET), that the TSH and lutropin (LH/CG) receptors form homo- and heterodimers, via interactions involving, primarily, their heptahelical domains. The large hormone-binding ectodomains were not essential for dimerization but adjusted protomer interaction. Contrary to a previous report, activation did not affect dimerization. Functional complementation, chieved by coexpression of mutant receptors unable to bind or signal, indicates that TSHr dimers may function as a single functional unit. Notably, heterologous binding-competition studies performed with heterodimers between TSHr and LH/CG-TSHr chimeras, demonstrated the unsuspected existence of strong negative cooperativity of hormone binding. Furthermore, radioligand desorption experiments highlighted an allosteric behavior in TSHr (confirmed in a native system) and, to a lesser extent, in LH/CGr and FSHr homodimers. This phenomenon seems to be a common property within the entire GPCR superfamily.
Elhuyar Fundazioa
Hormone Receptors News and Current Hormone Receptors Events RSSHSP90: New point of view on melanoma of the eye, at the MUHC
Ocular melanoma is rarely detected before it has grown large enough to impair vision or to metastasize. This makes it a particularly challenging disease to fight, especially since chemotherapy is not very effective.
Jefferson scientists find protein potential drug target for treatment-resistant prostate cancer
Scientists at Jefferson's Kimmel Cancer Center in Philadelphia have found that a signaling protein that is key to prostate cancer cell growth is turned on in nearly all recurrent prostate cancers that are resistant to hormone therapy.
Dartmouth researchers show effects of low dose arsenic on development
A team of Dartmouth Medical School (DMS) researchers has determined that low doses of arsenic disrupt the activity of a hormone critical in development.
Two Proteins May Be Survival Markers in Some Breast Cancers
New research suggests that the presence or absence of two proteins may be important markers for long-term survival in some breast-cancer patients.
Molecular signature may identify cisplatin-sensitive breast tumors
Researchers at the Massachusetts General Hospital (MGH) Cancer Center have identified a subgroup of hard-to-treat breast cancers that may be sensitive to the drug cisplatin, rarely used in the treatment of breast tumors.
Discovery in plants suggests entirely new approach to treating human cancers
For the first time, scientists from the University of Washington School of Medicine, Indiana University Bloomington and the University of Cambridge have determined how a plant hormone — auxin — interacts with its hormone receptor, called TIR1.
How appetite-stimulating brain cells work overtime during fasting
During periods of fasting, brain cells responsible for stimulating the appetite make sure that you stay hungry. Now, a new study of mice reported in the January issue of the journal Cell Metabolism, published by Cell Press, reveals the complex series of molecular events that keep those neurons active.
Professor analyzes nuclear receptors in bee genome
Susan Fahrbach, a Wake Forest University biologist, is among the more than 170 researchers who helped decode the honey bee genome.
Women on hormone therapy regain emotion response
Older women on hormone therapy are more sensitive to negative events, confirming speculation that age-related estrogen loss affects the brain's ability to process emotion, an Oregon Health & Science University study shows.
Preclinical study shows chronic stress agitates ovarian cancer; reducing stress slows tumor growth
When mice with ovarian cancer are stressed, their tumors grow and spread more quickly, but that effect can be blocked using a medication commonly prescribed for heart disease.
More Hormone Receptors News Articles
 | The Feel-Good Diet by Cheryle R. Hart, Mary Kay Grossman No cravings. No stress. No fatigue. Finally, a diet you can feel good about! Introducing The Feel-Good Diet, a scientific breakthrough in weight loss that will help you: Turn off your hunger Turn on your energy Tone up your body And "yo-yo" no more! The Feel-Good Diet is a revolutionary weight-loss program that works with you, not against you. Cheryle Hart, M.D., and Mary Kay... |
 | Cognitive Enhancing Drugs (Milestones in Drug Therapy) During the past decade research into the pharmacology of cognition, particularly regarding learning and memory, has supported the concept that many potential neural targets exist for the development of cognitive-enhancing drugs. Whereas the main impetus for this research has been the ever growing population of individuals with dementing disorders such as Alzheimer`s disease, attention is also... |
 | The Nuclear Receptor FactsBook (Factsbook) The FactsBook Series has established itself as the best source of easily accessible and accurate facts about protein groups. They use an easy-to-follow format and are researched and compiled by experts in the field.This Factsbook is devoted to nuclear receptors. The first section presents an introduction and describes the mode of action of the receptors in general. The second section of the book... |
 | Molecular Endocrinology: Genetic Analysis of Hormones and their Receptors (Human Molecular Genetics) by G. Rumsby This book comprehensively reviews the current developments in endocrinology and the techniques available for the molecular analysis of endocrine systems. Gene structure, regulation and methods of analysis are first described, followed by coverage of hormone receptors and intracellular signaling in relation to peptide hormones and the steroid hormone receptor superfamily. The biochemistry and... |
 | Neurosteroid Effects in the Central Nervous System: The Role of the GABA-A Receptor (Methods and New Frontiers in Neuroscience) Our understanding of the ways that neuroactive steroids act in the brain has been increased by transgenic approaches, recombinant expression systems, higher resolution electrophysiological paradigms, and the development of technology to localize receptors. Recent behavioral studies examining the effects of steroids on mood, seizure susceptibility, reproductive function, and sensorimotor control... |
| The Estrogen Receptor As Target for Rational Drug Design (Molecular Biology Intelligence Unit) by Erwin, Ph.D. Von Angerer | |
| The Melanocortin System (Annals of the New York Academy of Sciences) | |
| Maternal glucocorticoid deficit affects hypothalamic-pituitary-adrenal function and behavior of rat offspring [An article from: Hormones and Behavior] by J.S. Wilcoxon, E.E. Redei This digital document is a journal article from Hormones and Behavior, published by Elsevier in 2007. The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser.Description: Detrimental consequences of prenatal stress include increased hypothalamic-pituitary-adrenal (HPA) function, anxiety and... | |
 | Androgens and Androgen Receptor: Mechanisms, Functions, and Clinical Applications Androgen Receptors is the most comprehensive and up to date volume on the topic, including discussions of the basic mechanisms of androgen-androgen receptor actions, their roles in the androgen-related diseases, and their potential clinical applications.Key topics covered include: -The discovery and cloning of the androgen receptor; -Androgen receptor coregulators; -Androgen related genes and... |
 | Reviews of Physiology, Biochemistry and Pharmacology / Volume 151 (Reviews of Physiology, Biochemistry and Pharmacology) |
| © 2008 BrightSurf.com |